Pioneering the AI Revolution in Global Healthcare

As the visionary Chairman and CEO of AtheroPoint™, a California-based company dedicated to cardiovascular and stroke risk assessment, Dr. Suri is fundamentally redefining how medical diagnostics, treatment, and monitoring are conceived and delivered worldwide. His groundbreaking introduction of the Preventive, Precision, and Personalized (P3) framework embodies an anytime-anywhere model that empowers data-driven, patient-centric healthcare, making advanced medical care more accessible and effective than ever before.

With a formidable career spanning over 25 years in the United States, Dr. Suri seamlessly converges engineering excellence, profound R&D expertise, and exceptional executive leadership. His illustrious career path includes influential roles at global technology giants such as IBM, Siemens, and Philips, as well as innovative firms like Eigen and, of course, AtheroPoint™. In each of these positions, he has been a driving force behind the critical translation of advanced AI and Generative AI into clinically validated solutions that have tangible impacts on patient outcomes. His inventive spirit is further underscored by an impressive portfolio of 50 U.S. patents, and he has been instrumental in securing essential regulatory clearances for medical technologies now widely adopted across global healthcare systems.

Beyond his executive and entrepreneurial endeavors, Dr. Suri is also a prolific and highly respected researcher. He has authored and published more than 400 papers in international journals indexed by the National Library of Medicine, contributing significantly to the scientific body of knowledge in his field. His academic prowess is strikingly evident in his H-index exceeding 100 and over 56,000 citations, milestones that have earned him recognition as the only CTO-entrepreneur worldwide to achieve such a distinguished record. Further cementing his intellectual contributions, he has co-authored over 100 books on artificial intelligence and medical devices, making complex topics accessible to a broader audience.

The journey of AtheroPoint™ itself is a testament to Dr. Suri's entrepreneurial resilience and vision. Starting from a modest garage with an initial investment of just ten paisa, he has meticulously scaled the company into a global enterprise. Today, AtheroPoint™ delivers its cutting-edge cardiology services, branded AtheroEdgeTM, across a diverse geographical footprint including the USA, India, Tanzania, Rwanda, Slovenia, and the Philippines. This expansive reach highlights the universal applicability and urgent need for his innovations.

Dr. Suri's relentless R&D achievements have garnered him significant accolades, including prestigious Lifetime Achievement Awards in both the USA and India, and the Aatmanirbhar Face of Bharat Award. His standing as a visionary shaping the future of healthcare is further reinforced by fellowships from numerous leading professional bodies. Dr. Jasjit S. Suri is not just transforming healthcare designs; he is an architect of a healthier, more technologically advanced future for humanity.